Skip to main content

REVIEW article

Front. Immunol.
Sec. Mucosal Immunity
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1552010
This article is part of the Research Topic Natural Constituents and Mucosal Immunity: Immune Protection and Treatment of Mucosal Barriers and Microbial Flora Using Omics Technologies and Gene Sequencing View all 4 articles

Influence of gut microbial metabolites on tumor immunotherapy: mechanisms and potential natural products

Provisionally accepted
Dongyang Li Dongyang Li 1*Xintian Lan Xintian Lan 1*Linyi Xu Linyi Xu 1Shuo Zhou Shuo Zhou 1*Haoming Luo Haoming Luo 1Xiaoying Zhang Xiaoying Zhang 2*Wenbo Yu Wenbo Yu 1*Yonggang Yang Yonggang Yang 1*Xiaoxue Fang Xiaoxue Fang 1*
  • 1 Changchun University of Chinese Medicine, Changchun, China
  • 2 First Affiliated Hospital of Jilin University, Changchun, Jilin Province, China

The final, formatted version of the article will be published soon.

    In recent years, tumor immunotherapy has made significant breakthroughs in the treatment of malignant tumors. However, individual differences in efficacy have been observed in clinical practice. There is increasing evidence that gut microbial metabolites influence the efficacy of distal tumor immunotherapy via the gut-liver axis, the gut-brain axis and the gut-breast axis, a process that may involve modulating the expression of immune cells and cytokines in the tumor microenvironment (TME). In this review, we systematically explore the relationship between gut microbial metabolites and tumor immunotherapy, and examine the corresponding natural products and their mechanisms of action. The in-depth exploration of this research area will provide new ideas and strategies to enhance the efficacy of tumor immunotherapy and mitigate adverse effects.

    Keywords: Gut microbial metabolites1, Tumor2, natural products3, Immune4, mechanism5

    Received: 27 Dec 2024; Accepted: 06 Feb 2025.

    Copyright: © 2025 Li, Lan, Xu, Zhou, Luo, Zhang, Yu, Yang and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Dongyang Li, Changchun University of Chinese Medicine, Changchun, China
    Xintian Lan, Changchun University of Chinese Medicine, Changchun, China
    Shuo Zhou, Changchun University of Chinese Medicine, Changchun, China
    Xiaoying Zhang, First Affiliated Hospital of Jilin University, Changchun, 130012, Jilin Province, China
    Wenbo Yu, Changchun University of Chinese Medicine, Changchun, China
    Yonggang Yang, Changchun University of Chinese Medicine, Changchun, China
    Xiaoxue Fang, Changchun University of Chinese Medicine, Changchun, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.